Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?

International journal of molecular sciences - 8 Feb 2021

D'Amico Silvia, Tempora Patrizia, Lucarini Valeria, Melaiu Ombretta, Gaspari Stefania, Algeri Mattia, Fruci Doriana

Abstract excerpt

Patients with coronavirus disease 2019 (COVID-19) have a wide variety of clinical outcomes ranging from asymptomatic to severe respiratory syndrome that can progress to life-threatening lung lesions. The identification of prognostic factors can help to improve the risk stratification of patients by promptly defining for each the most effective therapy to resolve the disease. The etiological agent causing COVID-19...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aminopeptidases
Share to Angiotensin-Converting Enzyme 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antigen Presentation

Share to COVID-19

Share to Minor Histocompatibility Antigens

Share to Renin-Angiotensin System

Share to SARS-CoV-2

Share to Virus Internalization

Source

Open in PubMed Open full text

Identifiers

PMID: 33567739
DOI: 10.3390/ijms22041705
PMCID: PMC7914632

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?PMID 33567739Read ↗

Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?Semantic proximity Read ↗

The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and TherapySemantic proximity Read ↗

SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease.Semantic proximity Read ↗

Angiotensin-converting enzyme 2—at the heart of the COVID-19 pandemicSemantic proximity Read ↗

The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 InfectionSemantic proximity Read ↗

ACE2: the molecular doorway to SARS-CoV-2Semantic proximity Read ↗

ACE2 in the Era of SARS-CoV-2: Controversies and Novel PerspectivesSemantic proximity Read ↗

Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugsSemantic proximity Read ↗

ACE2: Its potential role and regulation in severe acute respiratory syndrome and COVID‐19Semantic proximity Read ↗

COVID-19: The Influence of ACE Genotype and ACE-I and ARBs on the Course of SARS-CoV-2 Infection in Elderly Patients.Semantic proximity Read ↗

The Intersection between COVID-19, the Gene Family of ACE2 and Alzheimer’s DiseaseSemantic proximity Read ↗

A Low Aldosterone/Renin Ratio and High Soluble ACE2 Associate with COVID-19 SeveritySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.